TMO
Thermo Fisher Scientific Inc.
$513.33
+11.97 (+2.39%)
At close · Jul 1
Insider flow:
Net -$185.1K over 90 days · 100% sells
1 Up Day
Indicators
Price
Panels
Event markers
Price & Indicators
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$513.33
Open$504.78
Day$502.87–521.17
52W$402.30–643.35
Avg vol 30d2.1M
Short int4.4M · 2.1d
Short vol46%
Last earningsApr 23, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 1
Equibles Rating
blended score
Overall
Buy
Technical · trend & momentum
Buy
+
Price vs 50-day avg · +8% above
◦
50 / 200-day cross
no cross
◦
Price vs 200-day avg
−2% below
+
Price vs 50-day avg
+8% above
◦
RSI (14)
64 · neutral
+
MACD trend
positive
◦
52-week position
46% · mid-range
Sentiment · smart money
Bullish
+
Institutional flow · 8 of 2,592 funds reported for Jun 30 · net +2.4K sh shares
◦
Trend (MA cross)
50d $473 › 200d $526 — 200d above 50d
+
Institutional flow
8 of 2,592 funds reported for Jun 30 · net +2.4K sh shares
−
Insider flow
Net -$185.1K over 90 days · 100% sells
+
Short interest
1.19% of float · ▼ -5.9% MoM · 2.1 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
2,592 holders — mid 3-yr range
Fundamentals
Strong
+
Revenue growth · +309% Y/Y
+
Revenue growth
+309% Y/Y
−
Gross margin
15%, contracting
◦
EPS growth
+7% Y/Y
+
Free cash flow
$6.3B
+
Valuation
P/E 28.2 · below peers
−
Balance sheet
net debt $32.9B
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Key facts
Market Cap
$190.76B
Shares
371,621,465
CIK
97745
CUSIP
883556102
13F Activity (30d)
105 filings
22 filers
Website
Visit website
Investor Relations
Investor relations
Up next
Next earnings call
Jul 24, 2026
Est · unconfirmed
· in 3 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 1, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−2% below
Neutral
Price vs 50-day avg
+8% above
Bullish
RSI (14)
64 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
46% · mid-range
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $473 › 200d $526 — 200d above 50d
Institutional flow
Accumulating
8 of 2,592 funds reported for Jun 30 · net +2.4K sh shares
Insider flow
Distributing
Net -$185.1K over 90 days · 100% sells
Short interest
Falling
1.19% of float · ▼ -5.9% MoM · 2.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
2,592 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $402
Now $513 · 46%
52-wk high $643
vs 200-day avg -2%
vs 50-day avg +8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Diagnostics & Research — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TMO
this stock
Thermo Fisher Scientific Inc.
|
$190.76B | -11.3% | +0.4% | 28.2 | 1.2% |
|
DHR
Danaher Corp /De/
|
$134.82B | -16.6% | +8.5% | 36.8 | 1.6% |
|
IDXX
Idexx Laboratories Inc /De
|
$42.41B | -20.5% | +10.4% | 39.6 | 2.7% |
|
NTRA
Natera, Inc.
|
$39.57B | +20.6% | -2.8% | — | 3.0% |
|
A
Agilent Technologies, Inc.
|
$37.52B | -2.0% | +6.4% | 26.7 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TMO | +4.3% | +6.5% | -16.7% | +2.4% | -11.3% |
| SPY | +1.7% | -1.8% | +8.2% | -0.1% | +9.4% |
| vs SPY | +2.6% | +8.3% | -24.9% | +2.5% | -20.7% |